Should we switch from analgesics to the concept of "Pain Modifying Analgesic Drugs (PMADs)" in osteoarthritis and rheumatic chronic pain conditions?
Perrot
Serge
S
Service de Médecine Interne et Thérapeutique, Consultation des douleurs rhumatologiques, Hotel Dieu, Université Paris Descartes, INSERM U792, 75004 Paris, France.
D000700:Analgesics / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D006801:Humans; D010003:Osteoarthritis / Q000150:complications* / Q000188:drug therapy* / Q000523:psychology; D010146:Pain / Q000188:drug therapy* / Q000209:etiology*; D012216:Rheumatic Diseases / Q000150:complications* / Q000188:drug therapy* / Q000523:psychology
D000700:Analgesics; D000928:Antidepressive Agents; D018501:Antirheumatic Agents
Arnold LM, Rosen A, Pritchett YL, D’Souza DN, Goldstein DJ, Iyengar S, Wernicke JF. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain. 2005;119:5-15.
Backman CL. Arthritis and pain. Psychosocial aspects in the management of arthritis pain. Arthritis Res Ther. 2006;8:221.
Baliki MN, Geha PY, Jabakhanji R, Harden N, Schnitzer TJ, Apkarian AV. A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis. Mol Pain. 2008;4:47.
Bradley LA. Psychiatric comorbidity in fibromyalgia. Curr Pain Headache Rep. 2005;9:79-86.
Chappell AS, Ossanna MJ, Liu-Seifert H, Iyengar S, Skljarevski V, Chunhong Li L, Bennett RM, Collins H. Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: A 13-week, randomized, placebo- controlled trial. Pain. 2009;146:253-260.
Felson DT, Niu J, Guermazi A, Roemer F, Aliabadi P, Clancy M, Torner J, Lewis CE, Nevitt MC. Correlation of the development of knee pain with enlarging bone marrow lesions on magnetic resonance imaging. Arthritis Rheum. 2007;56:2986-2992.
Fraenkel L, Bogardus ST Jr, Concato J, Wittink DR. Treatment options in knee osteoarthritis: the patient’s perspective. Arch Intern Med. 2004;164:1299-12304.
Imamura M, Imamura ST, Kaziyama HH, Targino RA, Hsing WT, de Souza LP, Cutait MM, Fregni F, de Souza LP, Camanho GL. Impact of nervous system hyperalgesia on pain, disability, and quality of life in patients with knee osteoarthritis: a controlled analysis. Arthritis Rheum. 2008;59:1424-1431.
Jensen MP, Dworkin RH, Gammaitoni AR, Olaleye DO, Oleka N, Galer BS. Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the neuropathic pain scale. J Pain. 2005;6:98-106.
Kivitz A, Fairfax M, Sheldon EA, Xiang Q, Jones BA, Gammaitoni AR, Gould EM. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults. Clin Ther. 2008;30:2366-2377.
Kulkarni B, Bentley DE, Elliott R, Julyan PJ, Boger E, Watson A, Boyle Y, El-Deredy W, Jones AK. Arthritic pain is processed in brain areas concerned with emotions and fear. Arthritis Rheum. 2007;56:1345-1354.
Lin EH, Katon W, Von Korff M, Tang L, Williams JW Jr, Kroenke K, Hunkeler E, Harpole L, Hegel M, Arean P, Hoffing M, Della Penna R, Langston C, Unützer J., IMPACT Investigators. Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial. JAMA. 2003;290:2428-2429.
Perrot S. Pathophysiology of joint pain. Joint Bone Spine. 2009;76:494-499.
Perrot S, Javier RM, Marty M, Le Jeunne C, Laroche F. CEDR. Is there any evidence to support the use of anti-depressants in painful rheumatological conditions? Systematic review of pharmacological and clinical studies. Rheumatology (Oxford). 2008;47:1117-1123.